The HCV Synthesis Project: scope, methodology, and preliminary results

Area of Science:

• Infectious Diseases
• Public Health
• Epidemiology

Background:

• Hepatitis C virus (HCV) is highly prevalent among individuals who inject drugs.
• HCV is also disproportionately found in non-injecting drug users who use substances like heroin, cocaine, crack, or methamphetamine via smoking or snorting.

Purpose of the Study:

• To synthesize existing research literature on Hepatitis C virus (HCV) prevalence, incidence, and genotype distribution among drug users.
• To identify knowledge gaps in the current body of research on HCV in drug-using populations.

Main Methods:

• Conducted a comprehensive literature synthesis of published and unpublished reports on HCV in drug users between 1989 and 2006.
• Employed rigorous search strategies and implemented a quality assurance system for data extraction and accuracy.
• Developed criteria to assess the quality of study designs in included reports.

Main Results:

• Identified 629 reports detailing HCV prevalence, incidence, or genotype distribution in injecting and non-injecting drug users from January 1989 to December 2006.
• Geographic distribution of reports: Western Europe (41%), North America (26%), Asia (11%), and Australia/New Zealand (10%), with additional reports from Eastern Europe, South America, the Middle East, and the Caribbean.
• Observed a significant increase in publications on HCV in drug users, rising to 27-52 reports annually after 1998.

Conclusions:

• The data collection and quality assurance for the HCV Synthesis Project are complete, providing a foundation for future research recommendations.
• Future studies should clearly define drug user participants by drug type and administration route to improve understanding of HCV etiology.
• Standardized reporting of risk factors is crucial for combining data across studies, particularly for HCV seroconversion research with limited sample sizes.